Janux Therapeutics Inc (JANX) — Strategic Asset Allocation Index
Janux Therapeutics Inc (JANX) has a Strategic Asset Allocation Index of 9.7% as of June 2023. Strategic assets (PP&E of $28.95 Million plus long-term investments of $-) total $28.95 Million, measured against net assets of $299.47 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Janux Therapeutics Inc balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Janux Therapeutics Inc Strategic Asset Allocation Index (2021–2022)
This chart shows how Janux Therapeutics Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of June 2023, the index stands at 9.7%, representing strategic assets of $28.95 Million against net assets of $299.47 Million USD. For live market cap and overall valuation, see Janux Therapeutics Inc (JANX) market capitalisation.
Annual Strategic Asset Allocation Index for Janux Therapeutics Inc (2021–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Janux Therapeutics Inc from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Janux Therapeutics Inc net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 2.2% | $7.09 Million | $7.09 Million | $- | $320.74 Million | ▲ +1.8 pp |
| 2021 | 0.4% | $1.60 Million | $1.60 Million | $- | $366.33 Million | — |